Arrowhead Pharmaceuticals (ARWR) Non-Current Deffered Revenue (2016 - 2026)
Arrowhead Pharmaceuticals' Non-Current Deffered Revenue was $31.74 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 34.7% from the prior quarter.
Powered by 
Analysis
Arrowhead Pharmaceuticals (ARWR) Non-Current Deffered Revenue (2016 - 2026) Analysis & Trends
At the end of FY2022 (ended Sep 30, 2022), Non-Current Deffered Revenue at Arrowhead Pharmaceuticals came in at $55.95 million, down 57.5% from FY2021.
- Non-Current Deffered Revenue shows a three-year compound annual growth rate of 123.1% (FY2019 to FY2022).
- In earlier fiscal years, Non-Current Deffered Revenue was $131.5 million in FY2021 and $5.04 million in FY2019.
- The fiscal Q3 2026 figure marks the lowest quarterly Non-Current Deffered Revenue since fiscal Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Arrowhead Pharmaceuticals | 9.24 Bn | 4.02 Bn | - | 31.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.74 Mn |
| Mar 31, 2026 | 48.62 Mn |
| Dec 31, 2025 | 53.83 Mn |
| Mar 31, 2023 | 1.08 Mn |
| Dec 31, 2022 | 40.79 Mn |
| Sep 30, 2022 | 55.95 Mn |
| Jun 30, 2022 | 71.16 Mn |
| Mar 31, 2022 | 89.75 Mn |
| Dec 31, 2021 | 106.46 Mn |
| Sep 30, 2021 | 131.50 Mn |
| Jun 30, 2021 | 79.75 Mn |
| Mar 31, 2021 | 121.53 Mn |
| Sep 30, 2019 | 5.04 Mn |
| Jun 30, 2019 | 22.26 Mn |
| Mar 31, 2019 | 29.73 Mn |
| Dec 31, 2018 | 33.17 Mn |
| Jun 30, 2017 | 625,000.00 |
| Mar 31, 2017 | 1.25 Mn |
| Dec 31, 2016 | 5.18 Mn |
| Sep 30, 2016 | 2.50 Mn |
API Access
Arrowhead Pharmaceuticals Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();